Advances in Hemophilia A: Expert Guidance and Practical Case Discussions

Gain insights into the latest advances in treatment of hemophilia A, including nonfactor and gene therapies, through expert-guided discussion and case-based examples.
Michael Callaghan, MD
Stacy Croteau Headshot
Stacy E. Croteau, MD, MMS
person default
Cindy A. Leissinger, MD
Guy A. Young, MD

ClinicalThought

With improved therapies, we can reduce the treatment burden of hemophilia A for patients. Here’s my take on how far we have come and where we are going.

Guy A. Young, MD Released: October 16, 2019

Here’s my take on some of the most exciting hemophilia A studies being presented at the upcoming ASH 2019 meeting in Orlando.

person default Cindy A. Leissinger, MD Released: December 3, 2019

What is the role of pharmacokinetic testing? What is the best option for previously untreated patients? Here’s our take.

Michael Callaghan, MD Stacy Croteau Headshot Stacy E. Croteau, MD, MMS person default Cindy A. Leissinger, MD Guy A. Young, MD Released: January 30, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue